NeoCore Technology Co., Ltd.
TWO: 4131.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Wen-Sheng Ji
- Employees
- 44
- Headquarters
- Tainan, Taiwan
- IPO year
- 2007
- Market cap
- NT$1.4B
- Website
- https://www.bio-drchip.com.tw
Loading 4131…
Loading profile data…Frequently asked questions about 4131
What does NeoCore Technology Co., Ltd. (4131.TWO) do?
NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company's products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers labo...
Where does 4131.TWO trade?
NeoCore Technology Co., Ltd. (4131.TWO) trades on the Taipei Exchange.
What sector is 4131.TWO in?
NeoCore Technology Co., Ltd. (4131.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of NeoCore Technology Co., Ltd.?
Wen-Sheng Ji is the chief executive officer of NeoCore Technology Co., Ltd. (4131.TWO).
Where is NeoCore Technology Co., Ltd. headquartered?
NeoCore Technology Co., Ltd. is headquartered in Taiwan.
Does 4131.TWO pay a dividend?
NeoCore Technology Co., Ltd. (4131.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4131.TWO go public?
NeoCore Technology Co., Ltd. (4131.TWO) completed its initial public offering in 2007.